Intertek

Activities: Regulatory Cleaning Nutraceutical

Trending Articles

  1. The perfect pair: how vitamins K2 and D3 combine to support health and well-being Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet...
  2. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  3. The role of traceability in the nutraceutical supply chain The exponential growth of the nutraceutical sector, combined with the unprecedented growth in online marketplaces, makes nutraceuticals highly vulnerable to vast counterfeiting...
  4. GOED releases two market research reports: annual global omega-3 ingredient market and consumer search trends The Global Organization for EPA and DHA Omega-3s (GOED) has published two important reports detailing trends in the global EPA and DHA omega-3 industry
  5. How to treat (and supplement) pets like part of the family Globally, 85% of pet parents agree that proper nutrition and supplements are as important for their pets as they are for themselves, writes Guillaume Maio, Marketing Manager,...

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

Related Content

Ingredients

Chinova enlists Intertek to prepare for GRAS ruling on mushroom fibre ingredient

Chinova Bioworks has received a No Questions Letter from the US FDA for its Chiber Mushroom Fiber, a natural food and beverage preservative
Skin Care

Intertek Clinical Research Services moves to new laboratory facility

Intertek Clinical Research Services has more than doubled the size of its laboratory, enabling it to accommodate and deliver larger projects for its customers
Regulatory

Testing conditions for Intertek as 2013 results move steadily forward

Growth of revenues of £2,184m (up 6.3%) and profits £343m (up 2.2%) masked some tough conditions in the chemicals and pharma division.
Subscribe now